SPARCL1 a novel player in cancer biology

被引:43
|
作者
Gagliardi, Filippo [1 ]
Narayanan, Ashwin [2 ]
Mortini, Pietro [1 ]
机构
[1] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Neurosurg & Gamma Knife Radiosurg, Milan, Italy
[2] UPMC, Sorbonne Univ, Neurosci Paris Seine IBPS, CNRS UMR8246,Inserm U113, F-75005 Paris, France
关键词
SPARCL1; Hevin; Matricellular proteins; Cancer; EXTRACELLULAR-MATRIX PROTEIN; MATRICELLULAR PROTEIN; GLYCOPROTEIN SC1/ECM2; TUMOR-SUPPRESSOR; HEVIN; SC1; ASTROCYTES; EXPRESSION; METALLOPROTEINASES; ANGIOGENESIS;
D O I
10.1016/j.critrevonc.2016.11.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Matricellular proteins are secreted, nonstructural proteins, involved in the mediation of molecular interactions between cells and extracellular microenvironment. They include several, structurally unrelated, members and their homologs. Among these a particularly interesting one is SPARCL1 due to its potential interactions in tumor biology. SPARCL1 is a secreted glycoprotein, belonging to SPARC family of matricellular proteins. It is implicated in the regulation of cell adhesion, migration, and proliferation. SPARCL1 is expressed in physiological context, both during embryogenesis and in adult life during tissue remodeling. Its diverse expression pattern in different forms of human cancers has suggested it may play different roles in tumor biology, as both oncogene and tumor suppressor, based on tumor type. Aim of this review is to critically revise current knowledges about the role, played by SPARCL1, in physiological and pathological contexts and highlight its role as a key-gene in the regulation of tumor biology. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 50 条
  • [1] SPARCL1 suppresses metastasis in prostate cancer
    Xiang, Yuzhu
    Qiu, Qingchao
    Jiang, Ming
    Jin, Renjie
    Lehmann, Brian D.
    Strand, Douglas W.
    Jovanovic, Bojana
    DeGraff, David J.
    Zheng, Yi
    Yousif, Dina A.
    Simmons, Christine Q.
    Case, Thomas C.
    Yi, Jia
    Cates, Justin M.
    Virostko, John
    He, Xiusheng
    Jin, Xunbo
    Hayward, Simon W.
    Matusik, Robert J.
    George, Alfred L., Jr.
    Yi, Yajun
    MOLECULAR ONCOLOGY, 2013, 7 (06) : 1019 - 1030
  • [2] Targeting adipose tissue to tackle NASH: SPARCL1 as an emerging player
    Rodrigues, Robim M.
    Guan, Yukun
    Gao, Bin
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (20):
  • [3] The oncogenic functions of SPARCL1 in bladder cancer
    Li, Changjiu
    Yuan, Hui
    Chen, Jun
    Shang, Kun
    He, Huadong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (22)
  • [4] SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer
    Zhang, Hai-Ping
    Wu, Jun
    Liu, Zhi-Feng
    Gao, Jing-Wen
    Li, Shu-Yu
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [5] SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer
    Zhang, Hai-Ping
    Wu, Jun
    Liu, Zhi-Feng
    Gao, Jing-Wen
    Li, Shu-Yu
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [6] Prognostic value of SPARCL1 in patients with colorectal cancer
    Han, Wei
    Cao, Fang
    Ding, Wei
    Gao, Xiao-Jiao
    Chen, Fang
    Hu, Yong-Wei
    Ding, Hou-Zhong
    ONCOLOGY LETTERS, 2018, 15 (02) : 1429 - 1434
  • [7] Associations of tumor suppressor SPARCL1 with cancer progression and prognosis
    Li, Ting
    liu, Xia
    Yang, Antai
    Fu, Wenjie
    Yin, Fuqiang
    Zeng, Xiaoyun
    ONCOLOGY LETTERS, 2017, 14 (03) : 2603 - 2610
  • [8] SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma
    Yu, Yang
    Chen, Yan
    Ma, Jianxia
    Yu, Xiaofeng
    Yu, Guanzhen
    Li, Zhaoshen
    TUMOR BIOLOGY, 2016, 37 (03) : 4159 - 4167
  • [9] SPARCL1 DEREGULATED IN ENDOMETRIOSIS LESIONS
    Ferriani, R. A.
    Meola, J.
    Hidalgo, G. dos S.
    Rosa e Silva, J. C.
    Paz, C. C. P.
    FERTILITY AND STERILITY, 2010, 94 (04) : S203 - S204
  • [10] Clinicopathological Significance of Reduced SPARCL1 Expression in Human Breast Cancer
    Cao, Fang
    Wang, Kuo
    Zhu, Rong
    Hu, Yong-Wei
    Fang, Wen-Zheng
    Ding, Hou-Zhong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (01) : 195 - 200